One of the most intriguing discoveries in autoimmunity are anti-pentraxin-3 (PTX3) antibodies, which have been detected in up to a third of RA patients who do not express ACPA (i.e. seronegative RA) [1]. Here, PRTN3 is linked to rheumatoid arthritis.